tiprankstipranks
Advertisement
Advertisement

SPRO Stock Latest News

Spero Therapeutics Co-Founder Resigns From Board Roles
Company AnnouncementsSpero Therapeutics Co-Founder Resigns From Board Roles
2M ago
8K
SPRO
GSK Resubmits NDA, Triggering Milestone for Spero Therapeutics
PremiumCompany Announcements
GSK Resubmits NDA, Triggering Milestone for Spero Therapeutics
4M ago
8K
SPRO
Spero announces GSK filed NDA resubmission to FDA for tebipenem HBr
PremiumThe Fly
Spero announces GSK filed NDA resubmission to FDA for tebipenem HBr
4M ago
GSK
SPRO
Spero Therapeutics announces inducement grant under Nasdaq listing rule
PremiumThe Fly
Spero Therapeutics announces inducement grant under Nasdaq listing rule
5M ago
SPRO
Spero Therapeutics Focuses on Tebipenem HBr Program
PremiumCompany Announcements
Spero Therapeutics Focuses on Tebipenem HBr Program
5M ago
SPRO
Spero Therapeutics Reports Q3 2025 Financial Results
PremiumCompany AnnouncementsSpero Therapeutics Reports Q3 2025 Financial Results
5M ago
8K
SPRO
Spero Therapeutics, GSK announce PIVOT-PO trial efficacy and safety results
Premium
The Fly
Spero Therapeutics, GSK announce PIVOT-PO trial efficacy and safety results
6M ago
GSK
SPRO
Spero Therapeutics’ Positive Earnings Call Highlights
Premium
Company Announcements
Spero Therapeutics’ Positive Earnings Call Highlights
8M ago
SPRO
Spero Therapeutics Reports Q2 2025 Results and Trial Success
PremiumCompany Announcements
Spero Therapeutics Reports Q2 2025 Results and Trial Success
8M ago
SPRO
Spero Therapeutics Reports Q2 2025 Financial Results
PremiumCompany Announcements
Spero Therapeutics Reports Q2 2025 Financial Results
8M ago
8K
SPRO
GSK and Spero Therapeutics Complete Promising Phase 3 Study on Oral Antibiotic for cUTI
PremiumCompany Announcements
GSK and Spero Therapeutics Complete Promising Phase 3 Study on Oral Antibiotic for cUTI
9M ago
GSK
SPRO
GSK and Spero Therapeutics: Phase 3 Study Completion on Oral vs. IV UTI Treatment
PremiumCompany Announcements
GSK and Spero Therapeutics: Phase 3 Study Completion on Oral vs. IV UTI Treatment
10M ago
GSK
SPRO
Spero Therapeutics Increases Stock Incentive Plan Shares
PremiumCompany AnnouncementsSpero Therapeutics Increases Stock Incentive Plan Shares
10M ago
8K
SPRO
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
10M ago
NNE
RKT
3 Penny Stocks to Watch Now, 5/29/25
Premium
Market News
3 Penny Stocks to Watch Now, 5/29/25
11M ago
SGN
SPRO
Spero Therapeutics Stock (SPRO) Rockets 225% on Clinical Trial Data
PremiumMarket News
Spero Therapeutics Stock (SPRO) Rockets 225% on Clinical Trial Data
11M ago
GSK
SPRO
Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories
PremiumMarket News
Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories
11M ago
M
KO
Spero Therapeutics’ Phase 3 Trial Meets Primary Endpoint
PremiumCompany Announcements
Spero Therapeutics’ Phase 3 Trial Meets Primary Endpoint
11M ago
8K
SPRO
GSK reports PIVOT-PO study for tebipenem HBr stopped early for efficacy
PremiumThe Fly
GSK reports PIVOT-PO study for tebipenem HBr stopped early for efficacy
11M ago
GSK
SPRO
Spero Therapeutics, GSK announce Phase 3 PIVOT-PO trial met primary endpoint
PremiumThe FlySpero Therapeutics, GSK announce Phase 3 PIVOT-PO trial met primary endpoint
11M ago
GSK
SPRO
Spero Therapeutics Reports Q1 2025 Results and Updates
Premium
Company Announcements
Spero Therapeutics Reports Q1 2025 Results and Updates
11M ago
SPRO
Spero Therapeutics Appoints New CEO Esther Rajavelu
Premium
Company Announcements
Spero Therapeutics Appoints New CEO Esther Rajavelu
12M ago
8K
SPRO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >